7Baggers
 Capital Increase in Genmab as a Result of Employee Warrant Exercise  Yahoo Finance Singapore Tue, 18 Nov 2025 19:58:00 GMT
 Genmab Reports FDA Approval for Epkinly in Follicular Lymphoma  MarketScreener Tue, 18 Nov 2025 19:45:49 GMT
 FDA Grants Full Approval to Genmab's (GMAB) Treatment EPKINLY fo  GuruFocus Tue, 18 Nov 2025 16:56:46 GMT
 AbbVie, Genmab win FDA label expansion for Epkinly (GMAB)  Seeking Alpha Tue, 18 Nov 2025 16:34:10 GMT
 Responsive Playbooks and the GMAB Inflection  news.stocktradersdaily.com Mon, 17 Nov 2025 15:40:01 GMT
 published on: 2025-11-15 19:01:11  newser.com Sun, 16 Nov 2025 01:01:11 GMT
 merus n.v. shareholders to vote on genmab acquisition offer  TipRanks Wed, 12 Nov 2025 13:43:09 GMT
 [defm14a] merus n.v. merger proxy statement  Stock Titan Wed, 12 Nov 2025 13:07:35 GMT
 genmab a/s (ge9.ha) stock price, news, quote and history  Yahoo Finance Singapore Wed, 12 Nov 2025 08:25:58 GMT
 Genmab A/S (NASDAQ:GMAB) Q3 2025 Earnings Call Transcript  Insider Monkey Tue, 11 Nov 2025 14:38:24 GMT
 fitch assigns first-time rating to genmab with stable outlook  MarketScreener Tue, 11 Nov 2025 04:50:11 GMT
 Fitch Rates Genmab A/S 'BB(EXP)'; Outlook Stable  TradingView Mon, 10 Nov 2025 15:01:29 GMT
 genmab announces proposed private offerings  MarketScreener Mon, 10 Nov 2025 12:18:20 GMT
 Genmab Announces Proposed Private Offering of Senior  GlobeNewswire Mon, 10 Nov 2025 12:12:42 GMT
 genmab a/s (ge9.sg) stock price, news, quote and history  Yahoo Finance UK Mon, 10 Nov 2025 11:11:30 GMT
 Genmab Provides Certain Information Disclosed in Connection  GlobeNewswire Mon, 10 Nov 2025 08:00:00 GMT
 Genmab to issue $2.5 billion in notes to finance Merus acquisition  Investing.com Mon, 10 Nov 2025 08:00:00 GMT
 genmab a/s (gmab) stock price | live quotes & charts | nasdaq  StocksToTrade Fri, 07 Nov 2025 21:43:00 GMT
 genmab reports strong financial growth and announces acquisition of merus  The Globe and Mail Fri, 07 Nov 2025 16:40:06 GMT
 genmab a/s (gmab.co) analyst insights, price targets and recommendations  Yahoo Finance UK Fri, 07 Nov 2025 15:59:50 GMT
 genmab reports strong revenue growth and strategic advances  TipRanks Fri, 07 Nov 2025 04:40:16 GMT
 transcript : genmab a/s, q3 2025 earnings call, nov 06, 2025  MarketScreener Fri, 07 Nov 2025 00:08:23 GMT
 gmab reports strong q3 revenue growth and key developments  GuruFocus Thu, 06 Nov 2025 16:49:15 GMT
 genmab a/s : first nine months 2025 financial results presentation  MarketScreener Thu, 06 Nov 2025 16:12:19 GMT
 genmab a/s : interim report for the first nine months of 2025  MarketScreener Thu, 06 Nov 2025 16:08:10 GMT
 genmab says nine months revenue increases 21% to $2,662 million  MarketScreener Thu, 06 Nov 2025 16:07:18 GMT
 Genmab Announces Financial Results for the Nine Months of 2025  GlobeNewswire Thu, 06 Nov 2025 16:02:22 GMT
 understanding the setup: (gmab) and scalable risk  news.stocktradersdaily.com Thu, 06 Nov 2025 14:30:02 GMT
 Genmab Reports Strong Revenue Growth and Strategic Advances  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 genmab as (gmab) q3 2025 earnings report preview: what to look for  Yahoo Finance Wed, 05 Nov 2025 12:20:41 GMT
 genmab to showcase latest blood cancer treatment  GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT
 short interest in genmab a/s (otcmkts:gnmsf) drops by 45.6%  MarketBeat Sat, 01 Nov 2025 09:08:57 GMT

Genmab A/S
(NASDAQ:GMAB) 

GMAB stock logo

Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye d...

Founded: 1999
Full Time Employees: 712
CEO: Jan G. J. van de Winkel  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends